The Registry of Toxic Effects of Chemical Substances
Phenol, 2,2' - methylenebis (3,4,6 - trichloro - |
UPDATE: November 2004 | MW: 406.89 | MF: C13H6Cl6O2 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | dog
3 mg/24 hour
|
N/R
|
AAOPAF 53,817,1955
|
eye | rabbit
1,500 mg/24 hour
|
N/R
|
AAOPAF 53,817,1955
|
skin | guinea pig
30 µg open irritation test
|
mild
|
JSCCA5 25,113,1974
|
skin | guinea pig
1,250 µg/24 hour
|
mild
|
JSCCA5 25,113,1974
|
skin | human
3 mg/3 day- intermittent
|
mild
|
85DKA8 -,127,1977
|
skin | human
50 µg/24 hour
|
mild
|
JSCCA5 25,113,1974
|
skin | rabbit
30 µg open irritation test
|
mild
|
JSCCA5 25,113,1974
|
skin | rabbit
1,250 µg/24 hour
|
mild
|
JSCCA5 25,113,1974
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 33,500 µg/m3/24 hour (1-20 day pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
|
GISAAA 49(8),25,1984
|
intravaginal | rat
lowest published toxic dose: 80 mg/kg (8-11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Eye, ear Reproductive: Specific developmental abnormalities: Urogenital system
AEHLAU 28,43,1974
|
intravaginal | rat
lowest published toxic dose: 300 mg/kg (8-11 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
AEHLAU 28,43,1974
|
oral | dog
lowest published toxic dose: 189 mg/kg (63 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
TOLED5 5,405,1980
|
oral | rat
lowest published toxic dose: 435 mg/kg (15-22 day pregnant/21 day after birth)
|
Reproductive: Effects on newborn: Stillbirth | Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
FCTXAV 14,421,1976
|
oral | rat
lowest published toxic dose: 137 mg/kg (14 week male/14 week prior to copulation-3 week after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
JAFCAU 23,866,1975
|
oral | rat
lowest published toxic dose: 50 mg/kg (7-8 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TJADAB 5,264,1972
|
oral | rat
lowest published toxic dose: 315 mg/kg (63 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
TOLED5 5,405,1980
|
subcutaneous | mouse
lowest published toxic dose: 75 mg/kg (7-12 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
PPASAK 49,110,1975
|
skin | mouse
lowest published toxic dose: 3,150 µg/kg (1-21 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
GISAAA 47(10),26,1982
|
skin | mouse
lowest published toxic dose: 31,500 µg/kg (1-21 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Other developmental abnormalities
GISAAA 47(10),26,1982
|
skin | mouse
lowest published toxic dose: 31.5 mg/kg (1-21 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
VCVGK* -,256,1994
|
skin | mouse
lowest published toxic dose: 3 mg/kg (7-8 day pregnant)
|
Reproductive: Other developmental abnormalities
|
VCVGK* -,256,1994
|
skin | mouse
lowest published toxic dose: 10.5 mg/kg (15-21 day pregnant)
|
Reproductive: Other developmental abnormalities
|
VCVGK* -,256,1994
|
skin | rat
lowest published toxic dose: 33 mg/kg (1-22 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
VCVGK* -,256,1994
|
skin | rat
lowest published toxic dose: 3 mg/kg (7-8 day pregnant)
|
Reproductive: Other developmental abnormalities
|
VCVGK* -,256,1994
|
skin | rat
lowest published toxic dose: 10.5 mg/kg (15-21 day pregnant)
|
Reproductive: Other developmental abnormalities
|
VCVGK* -,256,1994
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 33,500 µg/m3/52 week
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
VOONAW 33(1),62,1987
|
skin | mouse
lowest published toxic dose: 8,400 mg/kg/21 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Skin and Appendages: Tumors
CNREA8 19,413,1959
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lethal concentration (50 percent kill): 290 mg/m3
|
N/R
|
GISAAA 49(8),25,1984
|
inhalation | rat
lethal concentration (50 percent kill): 340 mg/m3
|
N/R
|
GISAAA 49(8),25,1984
|
intraperitoneal | dog
lowest published lethal dose: 25 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
intraperitoneal | guinea pig
lowest published lethal dose: 25 mg/kg
|
N/R
|
AIPTAK 163,210,1966
|
intraperitoneal | mouse
lethal dose (50 percent kill): 20 mg/kg
|
N/R
|
ZMMPAO 234,110,1976
|
intraperitoneal | mouse
lowest published lethal dose: 10 mg/kg
|
N/R
|
VCVGK* -,255,1994
|
intraperitoneal | rat
lethal dose (50 percent kill): 22 mg/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Somnolence (general depressed activity) Nutritional and Gross Metabolic: Body temperature increase
TXAPA9 24,239,1973
|
intraperitoneal | rat
lethal dose (50 percent kill): 22 mg/kg
|
N/R
|
VCVGK* -,255,1994
|
intravenous | dog
lowest published lethal dose: 5 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Respiratory depression Blood: Change in clotting factors
SURGAZ 24,542,1948
|
intravenous | dog
lowest published lethal dose: 5 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
intravenous | rat
lethal dose (50 percent kill): 7,500 µg/kg
|
Behavioral: Somnolence (general depressed activity) | Gastrointestinal: Hypermotility, diarrhea
TXAPA9 25,332,1973
|
intravenous | rat
lethal dose (50 percent kill): 7.5 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
intravenous | rabbit
lethal dose (50 percent kill): 8.5 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
oral | child
lowest published lethal dose: 250 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Cyanosis Lung, Thorax, or Respiration: Other changes
MJAUAJ 1,737,1963
|
oral | dog
lowest published lethal dose: 40 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
oral | domestic animal
lethal dose (50 percent kill): 30 mg/kg
|
N/R
|
ANYAA9 320,426,1979
|
oral | guinea pig
lethal dose (50 percent kill): 60 mg/kg
|
N/R
|
NIIRDN 6,742,1982
|
oral | guinea pig
lowest published lethal dose: 50 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
oral | human
lowest published lethal dose: 200 mg/kg
|
Brain and Coverings: Other degenerative changes | Gastrointestinal: Nausea or vomiting Nutritional and Gross Metabolic: Dehydration
VCVGK* -,256,1994
|
oral | infant
lowest published toxic dose: 257 mg/kg/7 day- intermittent
|
Gastrointestinal: Nausea or vomiting | Gastrointestinal: Hypermotility, diarrhea Vascular: Shock
AJDCAI 111,333,1966
|
oral | mouse
lethal dose (50 percent kill): 67 mg/kg
|
Lung, Thorax, or Respiration: Chronic pulmonary edema or congestion | Liver: Fatty liver degeneration Kidney, Ureter, and Bladder: Other changes
CMJOAP 82,691,1963
|
oral | mouse
lethal dose (50 percent kill): 67 mg/kg
|
N/R
|
VCVGK* -,255,1994
|
oral | rat
lethal dose (50 percent kill): 56 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Gastrointestinal: Hypermotility, diarrhea
TXAPA9 25,332,1973
|
oral | rat
lethal dose (50 percent kill): 50 mg/kg
|
N/R
|
VCVGK* -,255,1994
|
oral | rabbit
lethal dose (50 percent kill): 40,690 µg/kg
|
N/R
|
TJADAB 20,413,1979
|
oral | woman
lowest published toxic dose: 600 mg/kg
|
Cardiac: Cardiomyopathy including infarction | Gastrointestinal: Nausea or vomiting
JAMAAP 181,587,1962
|
subcutaneous | mouse
lethal dose (50 percent kill): 46 mg/kg
|
N/R
|
NEZAAQ 16,13,1961
|
subcutaneous | rat
lethal dose (50 percent kill): 7,650 µg/kg
|
N/R
|
IMSUAI 38,64,1969
|
skin | guinea pig
lethal dose (50 percent kill): 1,100 mg/kg
|
N/R
|
GISAAA 47(10),26,1982
|
skin | mouse
lethal dose (50 percent kill): 270 mg/kg
|
N/R
|
GISAAA 47(10),26,1982
|
skin | rat
lethal dose (50 percent kill): 1,840 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
skin | rat
lowest published lethal dose: 600 mg/kg
|
N/R
|
VCVGK* -,256,1994
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 420 mg/kg/7 day- intermittent
|
Brain and Coverings: Other degenerative changes | Autonomic Nervous System: Other (direct) parasympathomimetic Biochemical: Metabolism (intermediary): Amino acids (including renal excretion)
AECTCV 16,631,1987
|
oral | mouse
lowest published toxic dose: 420 mg/kg/7 day- intermittent
|
Brain and Coverings: Increased intracranial pressure | Brain and Coverings: Demyelination Nutritional and Gross Metabolic: Weight loss or decreased weight gain
VCVGK* -,256,1994
|
oral | mouse
lowest published toxic dose: 350 mg/kg/14 day- intermittent
|
Brain and Coverings: Increased intracranial pressure | Brain and Coverings: Demyelination Nutritional and Gross Metabolic: Weight loss or decreased weight gain
VCVGK* -,256,1994
|
oral | rat
lowest published toxic dose: 2,730 mg/kg/13 week- continuous
|
Brain and Coverings: Changes in brain weight | Autonomic Nervous System: Other (direct) parasympathomimetic Behavioral: Muscle weakness
TXAPA9 27,591,1974
|
oral | rat
lowest published toxic dose: 1,669 mg/kg/16 week- continuous
|
Brain and Coverings: Other degenerative changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
TXAPA9 24,239,1973
|
oral | rat
lowest published toxic dose: 2,450 mg/kg/14 week- continuous
|
Brain and Coverings: Changes in brain weight | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
AEHLAU 23,114,1971
|
oral | rat
lowest published toxic dose: 360 mg/kg/9 day- intermittent
|
Brain and Coverings: Other degenerative changes | Brain and Coverings: Changes in brain weight Eye: Optic nerve neuropathy
FAATDF 11,519,1988
|
oral | rat
lowest published toxic dose: 1,250 mg/kg/50 day- intermittent
|
Brain and Coverings: Changes in brain weight | Behavioral: Alteration of operant conditioning Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 9,331,1978
|
skin | dog
lowest published toxic dose: 58,800 mg/kg/12 week- intermittent
|
Eye: Mydriasis (pupilliary dilation) | Eye: Other eye effects
TOLED5 5,77,1980
|
skin | guinea pig
lowest published toxic dose: 1,500 mg/kg/30 day- intermittent
|
Liver: Fatty liver degeneration | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Biochemical: Metabolism (intermediary): Lipids including transport
JTOTDO 13,317,1994
|
skin | human
lowest published toxic concentration: 3 pph/4 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
VCVGK* -,256,1994
|
skin | rat
lowest published toxic dose: 1,440 mg/kg/30 day- intermittent
|
Brain and Coverings: Other degenerative changes | Skin: After systemic exposure: Dermatitis, other
TXAPA9 19,375,1971
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 20,241,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 20,241,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 3
|
IMSUDL 7,56,1987
|
TOXICOLOGY REVIEW
|
|
JCPCBR 13,439,1973
|
TOXICOLOGY REVIEW
|
|
AEHLAU 23,119,1971
|
TOXICOLOGY REVIEW
|
|
JACHDX 1,263,1975
|
TOXICOLOGY REVIEW
|
|
PLMJAP 5,100,1974
|
TOXICOLOGY REVIEW
|
|
PRTODI 1,56,1973
|
TOXICOLOGY REVIEW
|
|
MUREAV 488,151,2001
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: Cancelled
|
RBREV* -,185,1998
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.1 mg/m3, Skin, JAN1993
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 36710; | Number of Industries 18; Total Number of Facilities 2,049; Number of Occupations 33; Total Number of Employees Exposed 88,875
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 36710; |
Number of Industries 11; Total Number of Facilities 3,480; Number of Occupations 41; Total Number of Employees Exposed 403,543; Total Number of Female Employees Exposed 351,670 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used in the manufacture of germicidal soaps and as a disinfectant
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NCI Carcinogenesis Bioassay (feed);no evidence:rat
|
NCITR* NCI-TR-40,1978
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85DKA8
|
"Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar,
eds., New York, Academic Press, Inc. 1977
|
AAOPAF
|
AMA Archives of Ophthalmology. (Chicago, IL) V.44(4)-63, 1950-60. For publisher
information, see AROPAW.
|
AECTCV
|
Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
|
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
AJDCAI
|
American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610)
V.1-80(3), 1911-50; V.100- 1960-
|
ANYAA9
|
Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New
York, NY 10021) V.1- 1877-
|
CMJOAP
|
Chinese Medical Journal (Peking, 1932-1966). (Peking, Peop. Rep. China) V.46-85, 1932-66.
For publisher information, see CHHTAT.
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUAI
|
Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher
information, see IOHSA5.
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
JACHDX
|
Journal of Antimicrobial Chemotherapy. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1975-
|
JAFCAU
|
Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office
Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953-
|
JAMAAP
|
JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL
60610) V.1- 1883-
|
JCPCBR
|
Journal of Clinical Pharmacology. (Hall Assoc., PO Box 482, Stamford, CT 06904) V.13-
1973-
|
JSCCA5
|
Journal of the Society of Cosmetic Chemists. (Soc. of Cosmetic Chemists, 1995 Broadway, Suite
1701, New York, NY 10023) V.1- 1947-
|
JTOTDO
|
Journal of Toxicology, Cutaneous and Ocular Toxicology. (Marcel Dekker, 270 Madison Ave., New
York, NY 10016) V.1- 1982-
|
MJAUAJ
|
Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd., 71-79 Arundel St., Glebe,
N.S.W., Australia) V.1- 1914-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NEZAAQ
|
Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto
Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946-
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
PLMJAP
|
Pahlavi Medical Journal. (Shiraz, Iran) V.1-9, 1970-78.
|
PPASAK
|
Proceedings of the Pennsylvania Academy of Science. (Pennsylvania Academy of Science, c/o
Treasurer, Gannon College, Perry Sg., Erie, PA 16501) V.1- 1924/26-
|
PRTODI
|
"Progress in Toxicology," Zbinden, G., New York, Springer-Verlag, 1973
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
SURGAZ
|
Surgery. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1937-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
VOONAW
|
Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37; V.1- 1955-
|
ZMMPAO
|
Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung
1: Originale, Reihe A: Medizinische Mikrobiologie und Parasitologie. (Stuttgart, Fed. Rep.
Ger.) V.217-245, 1971-79.
|
|